Ms. Joyce Marie Quinn Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Whippany Rd, Whippany, NJ 07981 Phone: 973-599-7500 |
Olga Weinberger, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1003 Meadow Brook Ct, Whippany, NJ 07981 Phone: 973-887-1239 |
Kurt Keena Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 27 Harriet Dr, Whippany, NJ 07981 Phone: 973-487-8780 |
Megan Januszanis, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 Manchester Dr, Whippany, NJ 07981 Phone: 973-809-3940 |
Amanda Paravati Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14 Llewelyn Ct, Whippany, NJ 07981 Phone: 908-403-8825 |
News Archive
Novartis Pharmaceuticals Corporation announced today that the company will work with Medicare-approved drug discount card sponsors to provide its products free of Novartis charges to low-income Medicare enrollees, after they have exhausted their $600 transitional assistance available from the government.
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today celebrated the completion of renovations to its U.S. headquarters in Bridgewater, New Jersey with a ribbon-cutting ceremony.
Royal Philips Electronics today announced that Philips iDose4, the latest generation of Philips iterative reconstruction technique, has nearly 500 sales. While iDose4 only began shipping in March, its success validates the desire of radiologists to be able to both acquire and reconstruct images in less time, with improved image quality at low dose.
Democrats are moving quickly to socialize American health care with the SCHIP expansion. Michael Tanner of the CATO Institute whined, "Shouldn't we at least talk about it?"
The Woman's Condom, a new female condom designed to be easy to use and more acceptable to women and their partners, has been prequalified by the World Health Organization/United Nations Population Fund. The approval marks a critical step forward in expanding options for female-initiated dual protection from pregnancy and sexually transmitted infections (STIs), including HIV.
› Verified 4 days ago